Cargando…
Renin-Angiotensin-System Inhibitors for the Prevention of Chemotherapy-Induced Peripheral Neuropathy: OncoToxSRA, a Preliminary Cohort Study
Chemotherapy-induced peripheral neuropathy (CIPN) is a frequent and dose-limiting adverse side effect of treatment. CIPN affects the oncological prognosis of patients, as well as their quality of life. To date, no specific pharmacological therapy has demonstrated effectiveness in preventing CIPN. Ac...
Autores principales: | Frachet, Simon, Danigo, Aurore, Labriffe, Marc, Bessaguet, Flavien, Quinchard, Bianca, Deny, Nicolas, Baffert, Kim-Arthur, Deluche, Elise, Sturtz, Franck, Demiot, Claire, Magy, Laurent |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9144468/ https://www.ncbi.nlm.nih.gov/pubmed/35629066 http://dx.doi.org/10.3390/jcm11102939 |
Ejemplares similares
-
Neuroprotective Effect of Ramipril Is Mediated by AT2 in a Mouse MODEL of Paclitaxel-Induced Peripheral Neuropathy
por: Bouchenaki, Hichem, et al.
Publicado: (2022) -
The Angiotensin II Type 2 Receptor, a Target for Protection and Regeneration of the Peripheral Nervous System?
por: Danigo, Aurore, et al.
Publicado: (2021) -
Ramipril Alleviates Oxaliplatin-Induced Acute Pain Syndrome in Mice
por: Bouchenaki, Hichem, et al.
Publicado: (2021) -
Candesartan restores pressure-induced vasodilation and prevents skin pressure ulcer formation in diabetic mice
por: Danigo, Aurore, et al.
Publicado: (2015) -
The Cholecystokinin Type 2 Receptor, a Pharmacological Target for Pain Management
por: Bernard, Amandine, et al.
Publicado: (2021)